Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ataxin 10 anticorps (C-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement Ataxin 10 dans IHC. Il présente une réactivité envers Humain, Souris et Rat et a été mentionné dans 3+ publications.
N° du produit ABIN965623

Aperçu rapide pour Ataxin 10 anticorps (C-Term) (ABIN965623)

Antigène

Voir toutes Ataxin 10 (ATXN10) Anticorps
Ataxin 10 (ATXN10)

Reactivité

  • 25
  • 24
  • 21
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
Humain, Souris, Rat

Hôte

  • 34
  • 4
Lapin

Clonalité

  • 37
  • 2
Polyclonal

Conjugué

  • 24
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Ataxin 10 est non-conjugé

Application

  • 36
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 4
  • 4
  • 3
  • 1
  • 1
Immunohistochemistry (IHC)
  • Épitope

    • 16
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    C-Term

    Purification

    Purified by antigen-specific affinity chromatography.

    Immunogène

    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human ATXN10(Ataxin-10)
  • Indications d'application

    ELISA, Western blotting: 1µg/ml for 2hrs.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    This antibody is stored in PBS, 50% glycerol

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C
  • Matsuura, Fang, Pearson, Jayakar, Ashizawa, Roa, Nelson: "Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier?" dans: American journal of human genetics, Vol. 78, Issue 1, pp. 125-9, (2005) (PubMed).

    Wiemann, Weil, Wellenreuther, Gassenhuber, Glassl, Ansorge, Böcher, Blöcker, Bauersachs, Blum, Lauber, Düsterhöft, Beyer, Köhrer, Strack, Mewes, Ottenwälder, Obermaier, Tampe, Heubner, Wambutt, Korn et al.: "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs. ..." dans: Genome research, Vol. 11, Issue 3, pp. 422-35, (2001) (PubMed).

    Matsuura, Yamagata, Burgess, Rasmussen, Grewal, Watase, Khajavi, McCall, Davis, Zu, Achari, Pulst, Alonso, Noebels, Nelson, Zoghbi, Ashizawa: "Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10." dans: Nature genetics, Vol. 26, Issue 2, pp. 191-4, (2000) (PubMed).

  • Antigène

    Ataxin 10 (ATXN10)

    Autre désignation

    ATXN10

    Sujet

    The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. Defects in ATXN10 are the cause of spinocerebellar ataxia type 10. SCA10 is an autosomal dominant disorder and is predominantly characterized by cerebellar ataxia seizures. In addition patients often show soft pyramidal signs, ocular dyskinesia, cognitive impairment, and/or behavioral disturbances. SCA10 has been recognized only in families of Mexican origin. The molecular basis of the disease is due to an ATTCT nucleotide repeat expansion in intron 9.
Vous êtes ici:
Chat with us!